GlassScriptPhysician profile
Jose Ruiz
NPI 1285739060
$1,951.95
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $434 · 2020: $108 · 2021: $297 · 2022: $1,113.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neuronetics, INC. | $376.16 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $298.77 | 2019-2022 | |
| Alkermes, INC. | $227.59 | 2019-2022 | |
| Abbvie INC. | $210.66 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $155.07 | 2019-2022 | |
| Allergan, INC. | $143.88 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $120.23 | 2019-2022 | |
| Ironshore Pharmaceuticals INC. | $70.91 | 2019-2022 | |
| Supernus Pharmaceuticals, INC. | $61.98 | 2021 | |
| Neurocrine Biosciences, INC. | $38.42 | 2022 | |
| Corium, LLC | $38.25 | 2021-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $36.88 | 2022 | |
| Sunovion Pharmaceuticals INC. | $32.87 | 2019-2021 | |
| Lundbeck LLC | $21.30 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $20.31 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Noven Therapeutics, LLC | $19.59 | 2021 | |
| Axsome Therapeutics, INC. | $19.55 | 2022 | |
| Idorsia Pharmaceuticals US INC | $19.05 | 2022 | |
| Neos Therapeutics, LP | $14.61 | 2019 | |
| Tris Pharma INC | $13.12 | 2019 | |
| Shire North American Group INC | $12.75 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Ruiz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.